The Athlete's Heart, ECG, and Differential Diagnosis with Hypertrophic Cardiomyopathy and Other Cardiomyopathies

Diagnosis and Management of Hypertrophic Cardiomyopathy

Volumn , Issue , 2007, Pages 367-381

  Pelliccia, Antonio ^a   Maron, Barry J ^b,c  

^a Institute of Sport Science   (Italy)

^b MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

^c TUFTS MEDICAL CENTER   (United States)

Author keywords

Angiotensin converting; Cardiomyopathies; Echocardiography; Electrocardiogram; Renin angiotensin aldosterone system

Indexed keywords

EID: 57549092234     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470987469.ch25     Document Type: Chapter

References (52)

1. Rost R, Hollmann W. Athlete's heart. Review of its historical assessment and new aspects. Int J Sports Med 1983; 4: 147-65.
2. Huston P, Puffer JC, MacMillan Rodney W. The athletic heart syndrome. N Engl J Med 1985; 315: 24-32.
3. Maron BJ. Structural features of the athlete heart as defined by echocardiography. J Am Coll Cardiol 1986; 7: 190-203.
4. Morganroth J, Maron BJ, Henry WL et al. Comparative left ventricular dimensions in trained athletes. Ann Intern Med 1975; 82: 521-4.
5. Ikaheimo MJ, Palatsi IJ, Takkunen JT. Noninvasive evaluation of the athletic heart: Sprinters versus endurance runners. Am J Cardiol 1979; 44: 24-30.
6. Nishimura T, Yamada Y, Kawai C. Echocardiographic evaluation of long-term effects of exercise on left ventricular hypertrophy and function in professional bicyclists. Circulation 1980; 61: 832-40.
7. Fagard R, Aubert A, Lysens R, Staessen J, Vanhees L, Amery A. Noninvasive assessment of seasonal variations in cardiac structure and function in cyclists. Circulation 1983; 67: 896-901.
8. Pelliccia A, Maron BJ, Spataro A, Proschan MA, Spirito P. The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes. N Engl J Med 1991; 324: 295-301.
9. Spirito P, Pelliccia A, Proschan M et al. Morphology of the 'athlete's heart' assessed by echocardiography in 947 elite athletes representing 27 sports. Am J Cardiol 1994; 74: 802-6.
10. Pelliccia A, Culasso F, Di Paolo FM, Maron BJ. Physiologic left ventricular cavity dilatation in elite athletes. Ann Intern Med 1999; 130: 23-31.
11. Pelliccia A, Maron BJ. Cardiac adaptations to exercise training. In: Harries M, Williams C, Stanish WD, Micheli LJ, eds. Oxford Textbook of Sports Medicine, 2nd edn. Oxford University Press, 1998: 301-20.
12. Longhurst JC, Kelly AR, Gonyea WJ et al. Chronic training with static and dynamic ex-ercise: Cardiovascular adaptation and response to exercise. Circ Res 1981; 48 (Suppl. I): I171-8.
13. Keul J, Dickuth HH, Simon G et al. Effect of static and dynamic exercise on heart volume, contractility, and left ventricular dimensions. Circ Res 1981; 48 (Suppl. I): I162-70.
14. Henry WL, Gardin JM, Ware JH. Echocardiographic measurements in normal subjects from infancy to old age. Circulation 1980; 62: 1054-61.
15. Gardin JM, Savage DD, Ware JH et al. Effect of age, sex, body surface area on echocardiographic left ventricular wall mass in normal subjects. Hypertension 1987; 9 (Suppl. II): II36-9.
16. Pelliccia A, Spataro A, Caselli G, Maron BJ. Absence of left ventricular wall thickening in athletes engaged in intense power training. Am J Cardiol 1993; 72: 1048-54.
17. Pelliccia A, Maron BJ, Culasso F, Spataro A, Caselli G. The athlete's heart in women: Echo- cardiographic characterization of 600 highly trained and elite female athletes. JAMA 1996; 276: 211-15.
18. Montgomery HE, Clarkson P, Dollery CM et al. Association of angiotensin-converting enzyme gene I/D polymorphism with change in left ventricular mass in response to physical training. Circulation 1997; 96: 741-7.
19. Karjalainen J, Kujala HM, Stolt A et al. Angiotensinogen gene M235T polymorphism predicts left ventricular hypertrophy in endurance athletes. J Am Coll Cardiol 1999; 34: 494-9.
20. Maron BJ, Pelliccia A, Spirito P. Cardiac disease in young trained athletes: Insights into methods for distinguishing athlete's heart from structural heart disease, with particular emphasis on hypertrophic cardiomyopathy. Circulation 1995; 91: 1596-601.
21. Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA 2002; 287: 130820.
22. Maron BJ. Sudden death in young athletes. New Engl J Med 2003; 349: 1064-75.
23. Maron BJ, Mitchell JH. 26th Bethesda Conference: Recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. J Am Coll Cardiol 1994; 24: 845-99.
24. Klues HG, Schiffers A, Maron BJ. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: Morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. J Am Coll Cardiol 1995; 26: 1699-708.
25. Maron BJ, Kragel AH, Roberts WC. Sudden death due to hypertrophic cardiomyopathy in the absence of increased left ventricular mass. Br Heart J 1990; 63: 308-10.
26. Spirito P, Maron BJ, Bonow RO et al. Occurrence and significance of progressive left ventricular wall thinning and relative cavity dilatation in patients with hypertrophic cardiomyopathy. Am J Cardiol 1987; 60: 123-9.
27. Pelliccia A, Avelar E, De Castro S, Pandian N. Global left ventricular shape is not altered as a consequence of physiologic remodeling in highly trained athletes. Am J Cardiol 2000; 86: 700-2.
28. Spirito P, Maron BJ, Chiarella F et al. Diastolic abnormalities in hypertrophic cardiomyo-pathy: Relation to magnitude of left ventricular hypertrophy. Circulation 1985; 72: 310-16.
29. Lewis JF, Spirito P, Pelliccia A et al. Usefulness of Doppler echocardiographic assessment of diastolic filling in distinguishing 'athlete's heart' from hypertrophic cardiomyopathy. Am J Cardiol 1992; 68: 296-300.
30. Maron BJ, Pelliccia A, Spataro A et al. Reduction in left ventricular wall thickness after deconditioning in highly trained Olympic athletes. Br Heart J 1993; 69: 125-8.
31. Pelliccia A, Maron BJ, De Luca R, Di Paolo FM, Spataro A, Culasso F. Remodeling of left ventricular hypertrophy in elite athletes after long-term deconditioning. Circulation 2002; 105: 944-9.
32. Maron BJ, Moller JH, Seidman CE et al. Impact of laboratory molecular diagnosis on contemporary diagnostic criteria for genetically transmitted cardiovascular diseases: Hypertrophic cardiomyopathy, long-QT syndrome, and Marfan syndrome. Circulation 1998; 98: 1460-71.
33. Venerando A, Rulli V. Frequency, morphology and meaning of the electrocardiographic anomalies found in Olympic marathon runners. J Sports Med 1964; 3: 135-41.
34. Lichtman J, O'Rourke RA, Klein A, Karliner JS. Electrocardiogram of the athlete: Alterations simulating those of organic heart disease. Arch Intern Med 1973; 132: 763-70.
35. Zeppilli P, Pirrami MM, Sassara M, Fenici R. T wave abnormalities in top ranking athletes: Effects of isoproterenol, atropine, and physical exercise. Am Heart J 1980; 100: 213-22.
36. Nishimura T, Kambara H, Chen CH et al. Noninvasive assessment of T-wave abnormalities on precordial electrocardiograms in middle-aged professional bicyclists. J Electrocardiol 1981; 14: 357-64.
37. Oakley DG, Oakley CM. Significance of abnormal electrocardiograms in highly trained athletes. Am J Cardiol 1982; 50: 985-9.
38. Zehender M, Meinertz T, Keul J, Just H. ECG variants and cardiac arrhythmias in athletes: Clinical relevance and prognostic importance. Am Heart J 1990; 119: 1378-91.
39. Maron BJ, Wolfson JK, Cirò E et al. Relation of electrocardiographic abnormalities and patterns of left ventricular hypertrophy identified by 2-dimensional echocardiography in patients with hypertrophic cardiomyopathy. Am J Cardiol 1983; 51: 189-94.
40. Manolio TA, Baughman KL, Rodeheffer R et al. Prevalence and etiology of idiopathic dilated cardiomyopathy. Am J Cardiol 1992; 69: 1458-66.
41. Thiene G, Nava A, Corrado D et al. Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med 1988; 318: 129-33.
42. Corrado D, Thiene G, Nava A et al. Sudden death in young competitive athletes: Clinico- pathologic correlation in 22 cases. Am J Med 1990; 89: 588-96.
43. Corrado D, Basso C, Schiavon M et al. Screening for hypertrophic cardiomyopathy in young athletes. N Engl J Med 1998; 339: 364-9.
44. Pelliccia A, Maron BJ, Culasso F et al. Clinical significance of abnormal electrocardiographic patterns in trained athletes. Circulation 2000; 102: 278-84.
45. Pelliccia A, DeLuca R, Di Paolo FM, Spataro A, Maron BJ. The long-term clinical sig-nificance of distinctly abnormal 12-lead ECG patterns highly suggestive of hypertrophic cardiomyopathy in trained athletes [abstract]. Circulation 2000; 18 (Suppl. II): II-420.
46. Gavazzi A, De Maria R, Renosto G et al. The spectrum of left ventricular size in dilated cardiomyopathy: Clinical correlates and prognostic implications. Am Heart J 1993; 125: 410-22.
47. Lauer MS, Evans CE, Levy D. Prognostic implications of subclinical left ventricular dila-tation and systolic dysfunction in men free of overt cardiovascular disease (the Framingham heart study). Am J Cardiol 1992; 70: 1180-4.
48. Redfield MM, Gersh BJ, Bailey KR, Rodeheffer RJ. Natural history of incidentally discov-ered, asymptomatic idiopathic dilated cardiomyopathy. Am J Cardiol 1994; 74: 737-9.
49. Hauser AM, Dressendorfer RH, Vos M, Hashimoto Y, Gordon S, Timmis G. Symmetric cardiac enlargement in highly trained endurance athletes: A two-dimensional echocar- diographic study. Am Heart J 1985; 109: 1038-44.
50. McKenna WJ, Thiene G, Nava A et al. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Br Heart J 1994; 71: 215-18.
51. Marcus FI. Right ventricular dysplasia: Evaluation and management in relation to sports activities. In: Estes NAM, Salem DN, Wang PJ, eds. Sudden Cardiac Death in the Athlete. Armonk, NY: Futura Publishing, 1998: 277-84.
52. Nava A, Bauce B, Basso C et al. Clinical profile and long-term follow-up of 37 families with arrhythmogenic right ventricular cardiomyopathy. J Am Coll Cardiol 2000; 36: 2226-33.